A Comparison of Tracheal Intubation Using the Totaltrack vs the Macintosh Laryngoscope in Obese Patients

NCT03106974 — Not applicable, Unknown, 1440 participants, AnestesiaR

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

A Comparison of Tracheal Intubation Using the Totaltrack vs the Macintosh Laryngoscope

RegistryNCT03106974, acronym Ovesion
StatusUnknown
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: quadruple, other
Enrollment1440 (Estimated)
SponsorAnestesiaR (Other)
ConditionsEndotracheal Intubation, Obesity, Desaturation, Ventilation
Interventionsorotracheal intubation Macintosh Laryngoscope, orotracheal intubation Totaltrack VLM (Device)
Datesstart 2017-05-01 (estimated), primary completion 2018-05-01 (estimated), completion 2019-05-01 (estimated), first posted 2017-04-11, last updated 2017-04-14
Locations1 site in Spain

Related Papers Related Patents Related Grants Related Experts
All trials for Endotracheal Intubation All trials for Obesity All trials of orotracheal intubation Macintosh Laryngoscope All trials of orotracheal intubation Totaltrack VLM

-Summary

Airway management in obese patients has to consider that mask ventilation (DMV) risk is increased and difficult tracheal intubation (DTI) risk may be increased too.

In obese patients, is essential to prevent early arterial oxygen desaturation related to a reduced functional residual capacity (FRC), atelectasis formation during anesthetic induction and after tracheal intubation, because oxygenation maintenance is the cornerstone of the airway management of the obese patient.

Endotracheal intubation is usually required to allow unrestricted surgical approach. The Macintosh laryngoscope is the standard method. However, sometimes this technique is ineffective and poorly tolerated by the obese patient.

The Totaltrack™ (MedComflow S.A., Barcelona, Spain) is a hybrid device, between a supraglottic airway and a videolaryngoscope with an anatomically shaped blade. It allows fibreoptic visualization of the larynx for tracheal intubation and was developed to aid both ventilation and tracheal intubation, at the time of anticipated and unanticipated difficult airway management.

However, despite its use in clinical practice, there are no comparative studies regarding direct laryngoscopy in obese patients.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Macintosh LaryngoscopeActive comparatorDevice: orotracheal intubation Macintosh Laryngoscopeorotracheal intubation (OTI) with Macintosh Laryngoscope Direct laryngoscopy
Totaltrack VLMActive comparatorDevice: orotracheal intubation Totaltrack VLMorotracheal intubation (OTI) with Totaltrack VlM Indirect laryngoscopy
  • orotracheal intubation Macintosh Laryngoscope (Device), also known as OTI: orotracheal intubation (OTI) after induction of anesthesia and complete relaxation
  • orotracheal intubation Totaltrack VLM (Device): orotracheal intubation (OTI) after induction of anesthesia and complete relaxation

+Outcome measures

Primary outcomes

  • saturation of blood oxygen at the end of orotracheal intubation [Time of Orotracheal intubation (TOTI) (up to 1 hour)]: We will compare the blood oxygen saturation at the end of orotracheal intubation with macintosh and totaltrack. The end of successful tracheal intubation will be established to obtain a curve of Capnography.

Secondary outcomes

  • Total time of successful intubation [Time of Orotracheal intubation (TOTI) (up to 1 hour)]: Total time of successful intubation
  • number of maneuvers [Time of Orotracheal intubation (TOTI) (up to 1 hour)]: number of maneuvers
  • IDS Scale [Time of Orotracheal intubation (TOTI) (up to 1 hour)]: IDS Scale
  • POGO Score [Time of Orotracheal intubation (TOTI) (up to 1 hour)]: POGO Score
  • Number of attempts of endotracheal intubation [Time of Orotracheal intubation (TOTI) (up to 1 hour)]: Number of attempts of endotracheal intubation
  • hemodynamic response [TOTI pre and postintubation (up to 10 minutes)]: hemodynamic response
  • Degree of satisfaction of the researcher [time of postintubation (up to 10 minutes)]: Visual Analogic Scale (0-5)
  • adverse effects encountered during intubation [Time of Orotracheal intubation (TOTI) (up to 1 hour)]: adverse effects encountered during intubation
  • Complications [Time Frame: TOTI and postintubation (up to 24 hours)]: Complications after intubation

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* BMI > 30.
* ASA 1-3
* Scheduled surgeries that require orotracheal intubation.
* General anesthesia with neuromuscular relaxation before intubation.
* Patients who sign informed consent.

Exclusion Criteria:

* ASA 4
* Difficult airway already known.
* Alterations of airway documented, with previous tracheostomy or involve anatomical alterations.
* General anesthesia that not require orotracheal intubation or neuromuscular relaxation.
* Symptomatic gastro-esophageal reflux.
* Lap-Band carrier.
* Allergy medications to use.
* Urgent surgery.

+Locations (1)

FacilityCityCountryStatus
Hospital Universitario Infanta LeonorMadrid, MadridSpainRecruiting

+Investigators

  • Maria Luisa Mariscal Flores, M.D., Principal investigator, Hospital Universitario Getafe
  • Míriam Sánchez Merchante, M.D., Principal investigator, Hospital Universitario Fundación Alcorcón
  • Sergio D. Bergese, M.D., Principal investigator, Clinical Faculty - Wexner Medical Center at The Ohio State University